niacinamide has been researched along with cyclosporine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 9 (40.91) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kass, GE; Meier, P; Richter, C; Schlegel, J | 1 |
| Atlef, N; Doll, N; Hermitte, L; Payan, MJ; Scheimann, A; Vague, P; Vialettes, B | 1 |
| Baroni, MG; Boccuni, ML; Buzzetti, R; Cavallo, MG; Fioriti, E; Mesturino, C; Pozzilli, P; Signore, A; Valente, L; Visalli, N | 1 |
| Ballardie, FW; Chalmers, RJ; Daley-Yates, PT; Edwards, BD; Lawson, RS; Maiza, A; O'Driscoll, JB; Testa, HJ | 1 |
| Andreani, D | 1 |
| Schernthaner, G | 1 |
| Dedukhova, VI; Malkevitch, NV; Simonian, RA; Skulachev, VP; Starkov, AA | 1 |
| Pritchard, JB; Sweet, DH | 1 |
| Carlen, PL; Frantseva, MV; Perez Velazquez, JL | 2 |
| Palmer, JP | 1 |
| Berne, C; Felldin, M; Foss, A; Källen, R; Korsgren, O; Moberg, L; Nilsson, B; Olsson, A; Salmela, K; Tibell, A; Tufveson, G | 1 |
| Rosenkrantz, WS | 1 |
| Intong, LR; Murrell, DF | 1 |
| Gupta, S | 1 |
| Skyler, JS | 1 |
| Chen, Y; Chernyavsky, A; Deng, W; Grando, SA; Kalantari-Dehaghi, M; Marchenko, S; Wang, PH | 1 |
| Banovic, F; Linder, KE; Olivry, T | 1 |
| Acharya, C; Acharya, P; Adamia, S; Ballestrero, A; Bergamaschi, M; Bruzzone, S; Caffa, I; Cagnetta, A; Cea, M; Damonte, G; Fraternali, G; Garuti, A; Gobbi, M; Mastracci, L; Montecucco, F; Nencioni, A; Patrone, F; Pierri, I; Provenzani, A; Salis, A; Soncini, D; Zucal, C | 1 |
| Bornhäuser, M; Brendel, C; Burchert, A; Charles, J; Ellenrieder, V; Gattenlöhner, S; Hessmann, E; Inselmann, S; Metzelder, SK; Michel, C; Neubauer, A; Rehberger, M; Sohlbach, K; Solovey, M; Stiewe, T; Ten Haaf, A; von Bonin, M; Wang, Y | 1 |
| Kumar, JSD; Mann, JJ; Mintz, A; Prabhakaran, J; Sai, KKS; Sattiraju, A | 1 |
4 review(s) available for niacinamide and cyclosporine
| Article | Year |
|---|---|
Progress in the immunointervention of type-1 diabetes mellitus.
Topics: BCG Vaccine; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Immunotherapy; Insulin; Niacinamide | 1995 |
Pemphigus: current therapy.
Topics: Animals; Antirheumatic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; Dog Diseases; Dogs; Glucocorticoids; Immunoglobulins, Intravenous; Mycophenolic Acid; Niacinamide; Organogold Compounds; Pemphigus; Sulfasalazine; Tacrolimus; Tetracycline | 2004 |
Immunotherapies in diabetes mellitus type 1.
Topics: Abatacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Azathioprine; Basiliximab; Chaperonin 60; Cyclosporine; Daclizumab; Diabetes Mellitus, Type 1; Diet; Etanercept; Exenatide; Fatty Acids, Unsaturated; Glutamate Decarboxylase; Humans; Hypoglycemic Agents; Immunoconjugates; Immunoglobulin G; Immunosuppressive Agents; Insulin; Interferon-alpha; Interleukin 1 Receptor Antagonist Protein; Islets of Langerhans Transplantation; Niacinamide; Peptide Fragments; Peptides; Primary Prevention; Pyrazines; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rituximab; Secondary Prevention; Sitagliptin Phosphate; Tertiary Prevention; Triazoles; Venoms; Vitamin D; Vitamins | 2012 |
Primary and secondary prevention of Type 1 diabetes.
Topics: Abatacept; Adolescent; Adult; Antibodies, Monoclonal, Humanized; Autoantibodies; Child; Child, Preschool; Cyclosporine; Diabetes Mellitus, Type 1; Diet; Fatty Acids, Omega-3; Female; Glutamate Decarboxylase; Glutens; Humans; Hypoglycemic Agents; Immunoconjugates; Infant; Infant Formula; Infant, Newborn; Insulin; Male; Niacinamide; Primary Prevention; Secondary Prevention; Vitamin D | 2013 |
2 trial(s) available for niacinamide and cyclosporine
| Article | Year |
|---|---|
Adjuvant therapy in recent onset type 1 diabetes at diagnosis and insulin requirement after 2 years.
Topics: Adjuvants, Pharmaceutic; Adolescent; Adult; Age of Onset; Child; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Follow-Up Studies; Humans; Insulin; Niacinamide | 1995 |
Mechanisms of mitochondrial damage in keratinocytes by pemphigus vulgaris antibodies.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Autoantibodies; Cell Line, Transformed; Cyclosporine; Enzyme Inhibitors; Female; Humans; Immunoglobulin G; Keratinocytes; Male; Mice; Mice, Inbred BALB C; Minocycline; Mitochondria; Niacinamide; Oxygen Consumption; Pemphigus; Reactive Oxygen Species; Vitamin B Complex | 2013 |
16 other study(ies) available for niacinamide and cyclosporine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition by cyclosporine A of the prooxidant-induced but not of the sodium-induced calcium release from rat kidney mitochondria.
Topics: Adenosine Diphosphate Ribose; Alloxan; Animals; Calcium; Cyclosporine; Female; Glutathione; Glutathione Disulfide; Hydrolysis; Kidney; Mitochondria; Mitochondria, Liver; NAD; Niacinamide; Oxidants; Peroxides; Rats; Rats, Inbred Strains; Sodium; tert-Butylhydroperoxide | 1991 |
High dose nicotinamide fails to prevent diabetes in BB rats.
Topics: Age Factors; Animals; Autoimmune Diseases; Blood Glucose; Cyclosporine; Deferoxamine; Diabetes Mellitus, Experimental; DNA Damage; Drug Evaluation, Preclinical; Hyperplasia; Insulin; Insulin Secretion; Islets of Langerhans; Models, Biological; NAD; Niacinamide; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Inbred BB | 1989 |
Altered clearance of N-1 methylnicotinamide associated with the use of low doses of cyclosporine.
Topics: Analysis of Variance; Cyclosporine; Drug Therapy, Combination; Humans; Kidney Function Tests; Kidney Tubules, Proximal; Metabolic Clearance Rate; Niacinamide; Nifedipine; Renal Circulation | 1994 |
[Prevention of juvenile diabetes (type 1): reality or fiction?].
Topics: Adolescent; Autoimmunity; Child; Child, Preschool; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Infant; Infant, Newborn; Insulin; Insulin Antibodies; Insulin Secretion; Niacinamide; Primary Prevention | 1994 |
Thyroxine induces cyclosporin A-insensitive, Ca2+-dependent reversible permeability transition pore in rat liver mitochondria.
Topics: Adenosine Diphosphate; Animals; Calcium; Cyclosporine; Egtazic Acid; Intracellular Membranes; Ionophores; Membrane Potentials; Mitochondria, Liver; Mitochondrial Swelling; Niacinamide; Nigericin; Permeability; Rats; Thyroxine; Uncoupling Agents | 1997 |
rOCT2 is a basolateral potential-driven carrier, not an organic cation/proton exchanger.
Topics: Animals; Biological Transport; Carrier Proteins; Cell Membrane; Cells, Cultured; Cyclosporine; Dogs; Female; Gene Library; In Vitro Techniques; Kinetics; Membrane Potentials; Niacinamide; Oocytes; Organic Cation Transport Proteins; Organic Cation Transporter 2; Probenecid; Quinacrine; Quinine; Rats; Recombinant Proteins; Tetraethylammonium; Xenopus laevis | 1999 |
Molecular mechanisms of free radical production and protective efficacies of antioxidants in in vitro ischemia-reperfusion.
Topics: Animals; Antioxidants; Cyclosporine; Free Radicals; Glutathione; Hippocampus; Niacinamide; Organ Culture Techniques; Pyramidal Cells; Rats; Reperfusion Injury; Vitamin E | 1999 |
Immunomodulatory therapy of human type 1 diabetes: lessons from the mouse.
Topics: Adoptive Transfer; Adult; Animals; Autoantibodies; Autoimmune Diseases; Cell Transplantation; Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Freund's Adjuvant; Glutamate Decarboxylase; Graft Enhancement, Immunologic; Graft Survival; H-2 Antigens; Humans; Immunosuppressive Agents; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Knockout; Multicenter Studies as Topic; Nephrectomy; Niacinamide; Pancreatectomy; T-Lymphocytes | 2001 |
Dynamics of intracellular calcium and free radical production during ischemia in pyramidal neurons.
Topics: Aniline Compounds; Animals; Brain Ischemia; Calcium; Calcium Channels; Calcium-Binding Proteins; Culture Techniques; Cyclosporine; Electron Transport Complex I; Fluorescent Dyes; Free Radicals; Heterocyclic Compounds, 3-Ring; Hippocampus; Intracellular Fluid; Mitochondria; NADH, NADPH Oxidoreductases; Niacinamide; Pyramidal Cells; Rats; Rats, Wistar; Reperfusion Injury; Rhodamines; Rotenone; Ruthenium Compounds; Xanthenes | 2001 |
Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation.
Topics: Arginine; Cells, Cultured; Chemokine CCL2; Cyclosporine; Enalapril; Gene Expression Regulation; Humans; Islets of Langerhans; Islets of Langerhans Transplantation; Kinetics; Niacinamide; Thromboplastin | 2003 |
Pemphigoid gestationis: current management.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Dapsone; Dermatologic Agents; Female; Goserelin; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Niacinamide; Pemphigoid Gestationis; Plasmapheresis; Pregnancy; Rituximab | 2011 |
Ciclosporin therapy for canine generalized discoid lupus erythematosus refractory to doxycycline and niacinamide.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Cyclosporine; Dermatologic Agents; Dog Diseases; Dogs; Doxycycline; Drug Therapy, Combination; Ketoconazole; Lupus Erythematosus, Discoid; Male; Niacinamide; Treatment Failure; Treatment Outcome | 2014 |
APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells.
Topics: Acrylamides; Adenosine Triphosphate; Aged; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Survival; Chromosome Aberrations; Cyclosporine; Drug Resistance, Neoplasm; Drug Synergism; Endoplasmic Reticulum Stress; Female; Gene Expression; Humans; Immunoglobulin Heavy Chains; Leukemia; Male; Membrane Potential, Mitochondrial; Middle Aged; Mitochondria; Mutation; NAD; Neoplasm Staging; Niacin; Niacinamide; Nicotinamide Phosphoribosyltransferase; Piperidines; Primary Cell Culture; Prognosis; Tumor Cells, Cultured; Unfolded Protein Response | 2015 |
NFATc1 as a therapeutic target in FLT3-ITD-positive AML.
Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Proliferation; Cyclosporine; Drug Resistance, Neoplasm; Flow Cytometry; fms-Like Tyrosine Kinase 3; Gene Expression Profiling; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; NFATC Transcription Factors; Niacinamide; Oligonucleotide Array Sequence Analysis; Phenylurea Compounds; Prognosis; Protein Kinase Inhibitors; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Sorafenib; Survival Rate; Tandem Repeat Sequences; Tumor Cells, Cultured | 2015 |
Radiosynthesis and evaluation of [
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Carbon Radioisotopes; Cell Line, Tumor; Cyclosporine; Glycogen Synthase Kinase 3; Humans; Isotope Labeling; Ligands; Male; Niacinamide; Positron-Emission Tomography; Radiopharmaceuticals; Rats, Sprague-Dawley | 2019 |